Tirzepatide is an FDA-approved weekly injection used for the treatment of type 2 diabetes. While it is primarily used as a medication for type 2 diabetes, it can also be prescribed off-label for weight loss purposes. Tirzepatide has been shown in clinical trials to promote weight loss, although it is not FDA-approved for weight loss.

Qyral's healthcare providers will prescribe a compounded version of tirzepatide, which may also include additional metabolic support ingredients. The pharmacy that will ship to you depends on your state of residence, and each pharmacy that Qyral partners with has its own unique set of metabolic support ingredients. Therefore, depending on the state, you may receive different metabolic support ingredients from the corresponding pharmacy.

Tirzepatide for weight loss works by reducing appetite and increasing feelings of fullness. It works by mimicking the effects of the natural hormones GLP-1 and GIP in the body. These hormones help regulate appetite and blood sugar levels in the body. The medication also slows gastric emptying (how long food stays in the stomach) and can result in feeling full sooner and staying full for a longer period of time.

At Qyral, we offer a compounded version of tirzepatide, which is prescribed by our healthcare providers. It's important to note that our tirzepatide is not associated with Eli Lilly and Company or the brand-name medication Mounjaro. Our products are compounded in a pharmacy using only the highest quality ingredients.

Choosing our compounded medication over brand-name medications can result in significant cost savings, as brand-name medications can be expensive and cost thousands of dollars. Additionally, one of the benefits of compounded pharmaceuticals is that your healthcare provider can customize the dosage specifically to your individual needs. This personalized approach can lead to more effective treatment outcomes.

Tirzepatide is generally considered safe when used as direct and under the supervision of a healthcare provider. However, like any medication, it can have potential side effects. Some common side effects of tirzepatide include nausea, vomiting, diarrhea, and constipation. These side effects are usually mild and go away over time. In rare cases, more serious side effects can occur, such as severe stomach problems or kidney problems.

It is important to talk to your healthcare provider about any potential risks and benefits of taking tirzepatide, and to report any side effects or concerns promptly.

To use tirzepatide, there are specific criteria that must be met. You must:

1. Be at least 18 years old.
2. Reside in or physically be located in one of the states where our services are available.
3. Demonstrate the need for medical treatment. If necessary, our team can assist you in obtaining recent lab results if requested by your healthcare provider.
4. Meet the FDA-approved criteria for these medications, which include having a body mass index (BMI) over 30 for individuals with obesity, and a BMI over 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol.
5. Not have any of the following conditions: Type 1 Diabetes, a history of pancreatitis, severe gastrointestinal (GI) disease, current gallbladder problems (excluding previous gallbladder removal/cholecystectomy), retinal impairment/diabetic retinopathy, bariatric surgery within the past 6 months, multiple endocrine neoplasia syndrome type 2 (MEN-2), or a history of medullary thyroid cancer.
6. Not be pregnant or nursing.

Your Qyral-affiliated provider will make the final determination regarding your qualification for the Weight Managment Program and may request additional information from you directly.